ATE441415T1 - Substituierte piperidin-derivate als somatostatin-sst1-rezeptorantagonisten - Google Patents
Substituierte piperidin-derivate als somatostatin-sst1-rezeptorantagonistenInfo
- Publication number
- ATE441415T1 ATE441415T1 AT06762563T AT06762563T ATE441415T1 AT E441415 T1 ATE441415 T1 AT E441415T1 AT 06762563 T AT06762563 T AT 06762563T AT 06762563 T AT06762563 T AT 06762563T AT E441415 T1 ATE441415 T1 AT E441415T1
- Authority
- AT
- Austria
- Prior art keywords
- receptor antagonists
- substituted piperidine
- piperidine derivatives
- sst1 receptor
- somatostatin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Immunology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0514615.4A GB0514615D0 (en) | 2005-07-15 | 2005-07-15 | Organic compounds |
| PCT/EP2006/006867 WO2007009662A1 (en) | 2005-07-15 | 2006-07-13 | Substituted piperidine derivatives as somatostatin sst1 receptor antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE441415T1 true ATE441415T1 (de) | 2009-09-15 |
Family
ID=34897328
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT06762563T ATE441415T1 (de) | 2005-07-15 | 2006-07-13 | Substituierte piperidin-derivate als somatostatin-sst1-rezeptorantagonisten |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US7754719B2 (de) |
| EP (1) | EP1909792B1 (de) |
| JP (1) | JP2009501180A (de) |
| KR (1) | KR20080025731A (de) |
| CN (1) | CN101222924A (de) |
| AT (1) | ATE441415T1 (de) |
| AU (1) | AU2006272049A1 (de) |
| BR (1) | BRPI0612994A2 (de) |
| CA (1) | CA2615236A1 (de) |
| DE (1) | DE602006008957D1 (de) |
| ES (1) | ES2333165T3 (de) |
| GB (1) | GB0514615D0 (de) |
| MX (1) | MX2008000709A (de) |
| PL (1) | PL1909792T3 (de) |
| PT (1) | PT1909792E (de) |
| RU (1) | RU2008105362A (de) |
| WO (1) | WO2007009662A1 (de) |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5149817A (en) | 1990-03-05 | 1992-09-22 | Shionogi & Co., Ltd. | Teirahydropyridine derivatives |
| EP0937065A1 (de) | 1996-10-31 | 1999-08-25 | Novo Nordisk A/S | Somatostatin agonisten und antagonisten mit starrer konformation |
| CA2316767A1 (en) * | 1999-09-01 | 2001-03-01 | Bridget Mccarthy Cole | Somatostatin antagonists and agonists that act at the sst subtype 2 receptor |
| US7115741B2 (en) | 2001-09-06 | 2006-10-03 | Levy Daniel E | 4-thieno[2,3-D]pyrimidin-4-YL piperazine compounds |
| GB0127008D0 (en) | 2001-11-09 | 2002-01-02 | Novartis Ag | Organic compounds |
| JPWO2004011430A1 (ja) | 2002-07-25 | 2005-11-24 | アステラス製薬株式会社 | ナトリウムチャネル阻害剤 |
-
2005
- 2005-07-15 GB GBGB0514615.4A patent/GB0514615D0/en not_active Ceased
-
2006
- 2006-07-13 US US11/995,725 patent/US7754719B2/en not_active Expired - Fee Related
- 2006-07-13 ES ES06762563T patent/ES2333165T3/es active Active
- 2006-07-13 PL PL06762563T patent/PL1909792T3/pl unknown
- 2006-07-13 EP EP06762563A patent/EP1909792B1/de active Active
- 2006-07-13 PT PT06762563T patent/PT1909792E/pt unknown
- 2006-07-13 AT AT06762563T patent/ATE441415T1/de active
- 2006-07-13 KR KR1020087001023A patent/KR20080025731A/ko not_active Application Discontinuation
- 2006-07-13 BR BRPI0612994-3A patent/BRPI0612994A2/pt not_active IP Right Cessation
- 2006-07-13 AU AU2006272049A patent/AU2006272049A1/en not_active Abandoned
- 2006-07-13 WO PCT/EP2006/006867 patent/WO2007009662A1/en active Application Filing
- 2006-07-13 CN CNA2006800259166A patent/CN101222924A/zh active Pending
- 2006-07-13 JP JP2008520800A patent/JP2009501180A/ja active Pending
- 2006-07-13 CA CA002615236A patent/CA2615236A1/en not_active Abandoned
- 2006-07-13 RU RU2008105362/04A patent/RU2008105362A/ru not_active Application Discontinuation
- 2006-07-13 DE DE602006008957T patent/DE602006008957D1/de active Active
- 2006-07-13 MX MX2008000709A patent/MX2008000709A/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| US7754719B2 (en) | 2010-07-13 |
| DE602006008957D1 (de) | 2009-10-15 |
| BRPI0612994A2 (pt) | 2010-12-14 |
| RU2008105362A (ru) | 2009-08-20 |
| EP1909792B1 (de) | 2009-09-02 |
| ES2333165T3 (es) | 2010-02-17 |
| PT1909792E (pt) | 2009-12-09 |
| EP1909792A1 (de) | 2008-04-16 |
| WO2007009662A1 (en) | 2007-01-25 |
| AU2006272049A1 (en) | 2007-01-25 |
| JP2009501180A (ja) | 2009-01-15 |
| MX2008000709A (es) | 2008-03-18 |
| CA2615236A1 (en) | 2007-01-25 |
| CN101222924A (zh) | 2008-07-16 |
| GB0514615D0 (en) | 2005-08-24 |
| PL1909792T3 (pl) | 2010-02-26 |
| US20080255142A1 (en) | 2008-10-16 |
| KR20080025731A (ko) | 2008-03-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE500250T1 (de) | Azetidinverbindungen als orexin-rezeptor- antagonisten | |
| ATE422198T1 (de) | Arylsulfonylnaphthalinderivate als 5ht2a- antagonisten | |
| ATE360627T1 (de) | Pyrrolidindion-substituierte piperidin- phthalazone als pde4-inhibitoren | |
| ATE518834T1 (de) | 2,3,4,9-tetrahydro-1h-carbazol-derivative als crth2-rezeptorantagonisten | |
| TW200637550A (en) | Thiazole-4-carboxamide derivatives as mGluR5 antagonists | |
| ATE496051T1 (de) | Pyrazolotetrahydropyridinderivate als orexinrezeptorantagonisten | |
| CY1109911T1 (el) | Πυρρολοβενζοδιαζεπινες | |
| EA200701396A1 (ru) | Триазолофталазины в качестве ингибиторов pde-2 | |
| BRPI0605921A2 (pt) | compostos orgánicos | |
| ATE441639T1 (de) | 2,4-diamino-pyrimidine als aurora inhibitoren | |
| ATE508119T1 (de) | Ä4,5'ü-bipyrimidinyl-6,4'-diaminderivate als proteinkinase-hemmer | |
| EA200801381A1 (ru) | Производные пиримидина | |
| EA200700365A1 (ru) | Производные индол-2-карбоксамидина как антагонисты nmda рецептора | |
| DE602006016303D1 (de) | 3,4-dihydro-2H-benzoÄ1,4Üoxazin- und 3,4-dihydro-2H-benzoÄ1,4Üthiazin-VERBINDUNGEN ALS ALPHA2C-ADRENOREZEPTOR-ANTAGONISTEN | |
| ATE376833T1 (de) | Chinazolinon-derivate als vanilloid-antagonisten | |
| NO20075987L (no) | Bisykliske derviater som p38-kinaseinhibitorer | |
| ATE553106T1 (de) | Heteroarylpyrrolopyridinone als kinaseinhibitoren | |
| TW200700396A (en) | Pyrazine-2-carboxamide derivatives as mglur5 antagonists | |
| WO2007056091A3 (en) | 2-phenyl-2h-pyraz0le derivatives as p2x7 receptor antagonists and uses thereof | |
| DK1954668T3 (da) | Homo- og heterocykliske forbindelser, der er egnede som CETP-inhibitorer | |
| EA200801366A1 (ru) | Производные 3,6-дигидро-2-оксо-6н-1,3,4-тиадиазина | |
| EA200801365A1 (ru) | Замещенные 5-фенил-3,6-дигидро-2-оксо-6h-1,3,4-тиадиазины | |
| ATE538787T1 (de) | Benzimidazol-derivative als raf-kinase-hemmer | |
| EA200801549A1 (ru) | Новые производные фенантридина в качестве антагонистов брадикинина | |
| MXPA05013149A (es) | Derivados de imidazol como antagonistas del receptor de glutamato. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1909792 Country of ref document: EP |